BETHANY KANE: Open Payments
NPI 1962838607 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 20 payments from 13 companies in 2025. Trend: 2023 $680 · 2024 $1,155 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
| Lilly USA, LLC | 2 | $44 |
| Almirall LLC | 2 | $40 |
| Organon LLC | 2 | $35 |
| UCB, Inc. | 1 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| ABBVIE INC. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: TREMFYA, DUPIXENT, Klisyri, VTAMA, Bimzelx, EBGLYSS, Winlevi, TALTZ.
Industry payments across PA — which companies pay providers there.
